Biosimilar antibody development at Bio-Techne includes in silico design and engineering to generate both light chain (lc) and heavy chain (hc) sequences for each antibody. After transfection of the dual expression ...read more
Recombinant Monoclonal Antibody For Research Use Only
Immunogen
Human CD25/IL-2 R alpha
Specificity
Detects human CD25/IL-2 R alpha in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Daclizumab. This product is for research use only.
Source
N/A
Isotype
IgG1
Clonality
Monoclonal
Host
Human
Purity Statement
Protein A or G purified from cell culture supernatant
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
12 months from date of receipt, 2 to 8 °C as supplied.
Buffer
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Notes
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for CD25/IL-2R alpha Antibody (Hu102) [Alexa Fluor® 647]
CD25 antigen
CD25
IDDM10
IL-2 R alpha
IL-2 receptor subunit alpha
IL2R alpha
IL-2R subunit alpha
IL2R
IL2RA
IL-2Ra
IL-2-RA
IL2-RA
interleukin 2 receptor, alpha
interleukin-2 receptor subunit alpha
p55
TAC antigen
TCGFR
Background
Daclizumab is a biosimilar directed against the extracellular domain of CD25/IL-2 R alpha . This product can be used flow cytometry or various assay formats to measure CD25/IL-2 R alpha expression.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for CD25/IL-2R alpha Antibody (FAB9927R) (0)
There are no reviews for CD25/IL-2R alpha Antibody (FAB9927R).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our CD25/IL-2R alpha Antibody (Hu102) [Alexa Fluor® 647] and receive a gift card or discount.